Abstract
Many men with erectile dysfunction (ED) have hypertension as a comorbid condition. Recent guidelines recommend thiazide diuretics as first-line therapy for hypertension. We analyzed data from 14 randomized, double-blind, placebo-controlled trials (N=2501) to evaluate the efficacy of tadalafil 20 mg for the treatment of ED in men on thiazides. Of the 2501 patients, 163 were on concomitant thiazides (116 tadalafil/47 placebo) and 159 (98%) were reported to have hypertension. The primary efficacy measures were mean change from baseline in the international index of erectile function (IIEF) erectile function (EF) domain and the proportion of ‘yes’ responses to sexual encounter profile (SEP) Questions 2 and 3. The tadalafil group showed a significantly (P<0.001) greater mean baseline to endpoint improvement on all efficacy outcome measures compared to placebo-treated patients regardless of concomitant thiazide use. More importantly, the responses to tadalafil were similar regardless of concomitant thiazide use. Additionally, responses to tadalafil were comparable between thiazide and nonthiazide users regardless of baseline ED severity (P>0.05).
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 8 print issues and online access
$259.00 per year
only $32.38 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Chobanian AV et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003; 289: 2560–2572.
Weiss RJ . Effects of antihypertensive agents on sexual function. Am Fam Physician 1991; 44: 2075–2082.
Chang SW et al. The impact of diuretic therapy on reported sexual function. Arch Intern Med 1991; 151: 2402–2408.
Grimm Jr RH et al. Long-term effects on sexual function of five antihypertensive drugs and nutritional hygienic treatment in hypertensive men and women. Treatment of Mild Hypertension Study (TOMHS). Hypertension 1997; 29: 8–14.
Wassertheil-Smoller S et al. Effect of antihypertensives on sexual function and quality of life: the TAIM Study. Ann Intern Med 1991; 114: 613–620.
Keene LC, Davies PH . Drug-related erectile dysfunction. Adverse Drug React Toxicol Rev 1999; 18: 5–24.
The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA 2002; 288: 2981–2997.
Cappelleri JC et al. Diagnostic evaluation of the erectile function domain of the International Index of Erectile Function. Urology 1999; 5: 346.
Brock GB et al. Efficacy and safety of tadalafil in the treatment of erectile dysfunction: results of integrated analyses. J Urol 2002; 168: 1332–1336.
Carson CC et al. The efficacy and safety of tadalafil: an update. Br J Urol Int 2004; 93: 1276–1281.
Acknowledgements
This study was supported by Lilly ICOS LLC (Bothell, Washington, Indianapolis, Indiana). We would like to acknowledge Dr Fanni Natanegara, PhD, for critically reviewing this manuscript.
Author information
Authors and Affiliations
Corresponding author
Additional information
Disclosures:
Dr Kloner is a consultant, researcher, and speaker for Lilly ICOS; Dr Kloner is also a consultant, speaker for Pfizer, and consultant to Bayer-GSK, Schering Plough, and Palatine/King Pharmaceuticals. Dr Sadovsky is a consultant and speaker for Lilly ICOS, Bayer-GSK, and Pfizer; Drs Johnson, Mo, and Ahuja are employees of Eli Lilly and Company.
Rights and permissions
About this article
Cite this article
Kloner, R., Sadovsky, R., Johnson, E. et al. Efficacy of tadalafil in the treatment of erectile dysfunction in hypertensive men on concomitant thiazide diuretic therapy. Int J Impot Res 17, 450–454 (2005). https://doi.org/10.1038/sj.ijir.3901360
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.ijir.3901360
Keywords
This article is cited by
-
The use of phosphodiesterase 5 inhibitors with concomitant medications
Journal of Endocrinological Investigation (2008)
-
Erectile dysfunction and hypertension
International Journal of Impotence Research (2007)
-
Phosphodiesterase-5 inhibitors and their hemodynamic effects
Current Hypertension Reports (2006)